Articles about HDT Bio

Seattle startup HDT Bio lands $1.8M U.S. Army grant to develop nasal spray against viruses

Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a… Read More

Seattle startup claims India-based drugmaker stole COVID-19 vaccine tech, seeks $950M

Seattle vaccine company HDT Bio is seeking nearly $1 billion in a new lawsuit alleging that an India-based drugmaker stole… Read More

DoD gives $1.1M to Seattle startup that will help find new antibodies against COVID-19 variants

Seattle-based A-Alpha Bio will support research into new therapies for COVID-19 variants in a collaboration with Lawrence Livermore National Laboratory.… Read More

Seattle’s HDT Bio to start U.S. clinical trials of its COVID-19 vaccine candidate

An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the U.S., the company… Read More

Next-gen vaccine from UW researchers shows promise in fighting COVID-19

University of Washington School of Medicine researchers using a cutting-edge approach to vaccinations report that their COVID-19 vaccine is performing… Read More